Zepbound 15 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F64U5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $51,247
Award facts
- Contract value 100% obligated
- $51,246.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Zepbound 15 mg/0.5 ml pen injections valued at $51,246.79 on January 2, 2026, with completion scheduled for January 5, 2026. This firm fixed-price, competitively awarded order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The work will be performed at the company's corporate office in Conshohocken, Pennsylvania. No set-aside designation was used for this procurement.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare supplier, fulfills extensive pharmaceutical and medical supply needs for military and veteran healthcare systems. The company's substantial prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling delivery of specialty medications, brand-name and generic drugs, vaccines, and related medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. Zepbound is a GLP-1 receptor agonist used for weight management treatment, consistent with AmerisourceBergen's portfolio of advanced pharmaceutical therapies across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F64U5?
SPE2DR26F64U5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 2, 2026.
How much is contract SPE2DR26F64U5 worth?
The government has obligated $51,247 on SPE2DR26F64U5.
Is contract SPE2DR26F64U5 an order under another contract?
Yes. SPE2DR26F64U5 is a delivery order under SPE2DR25D3303, an indefinite delivery contract.
Was contract SPE2DR26F64U5 competed?
The extent of competition for SPE2DR26F64U5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award